{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:50:24Z","timestamp":1793620224678,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.amjmed.2024.10.016","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:01:10Z","timestamp":1729126870000},"page":"449-457.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative Analysis of First-Line Antihypertensive Treatment Classes"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-6498","authenticated-orcid":false,"given":"Ran","family":"Abuhasira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitzan","family":"Burrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Turjeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan Shneor","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjmed.2024.10.016_bib0001","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjmed.2024.10.016_bib0002","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"10010","key":"10.1016\/j.amjmed.2024.10.016_bib0003","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Forouzanfar","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.amjmed.2024.10.016_bib0004","article-title":"First-line drugs for hypertension","volume":"2018","author":"Wright","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"38","key":"10.1016\/j.amjmed.2024.10.016_bib0005","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.amjmed.2024.10.016_bib0006","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertensi","volume":"41","author":"Mancia(Chairperson)","year":"2023","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.amjmed.2024.10.016_bib0007","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08037051.2013.812549","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension","volume":"22","author":"Mancia","year":"2013","journal-title":"Blood Press"},{"issue":"1","key":"10.1016\/j.amjmed.2024.10.016_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J Hypertens"},{"issue":"17","key":"10.1016\/j.amjmed.2024.10.016_bib0009","first-page":"e426","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.amjmed.2024.10.016_bib0010","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.amjmed.2024.10.016_bib0011","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"issue":"7","key":"10.1016\/j.amjmed.2024.10.016_bib0012","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/HJH.0000000000000614","article-title":"Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs-overview andmeta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J Hypertens"},{"issue":"8","key":"10.1016\/j.amjmed.2024.10.016_bib0013","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/HJH.0000000000001777","article-title":"Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality","volume":"36","author":"Thomopoulos","year":"2018","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.amjmed.2024.10.016_bib0014","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/jch.13531","article-title":"First-line treatment of essential hypertension: a real-world analysis across four antihypertensive treatment classes","volume":"21","author":"Stapff","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10211","key":"10.1016\/j.amjmed.2024.10.016_bib0015","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0140-6736(19)32317-7","article-title":"Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis","volume":"394","author":"Suchard","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2024.10.016_bib0016","series-title":"Collection of Statistical Data - 20 Years of the National Health Insurance Law","year":"2015"},{"issue":"1","key":"10.1016\/j.amjmed.2024.10.016_bib0017","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/HYPERTENSIONAHA.119.13820","article-title":"Investigation and treatment of high blood pressure in young people: too much medicine or appropriate risk reduction?","volume":"75","author":"Hinton","year":"2020","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"691","key":"10.1016\/j.amjmed.2024.10.016_bib0018","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3399\/bjgp20X708053","article-title":"Diagnosis and management of hypertension in adults: NICE guideline update 2019","volume":"70","author":"Jones","year":"2020","journal-title":"Br J Gen Pract"},{"issue":"4","key":"10.1016\/j.amjmed.2024.10.016_bib0019","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004872-200204000-00037","article-title":"Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs","volume":"20","author":"Deary","year":"2002","journal-title":"J Hypertens"},{"issue":"9169","key":"10.1016\/j.amjmed.2024.10.016_bib0020","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(98)07614-4","article-title":"Optimisation of antihypertensive treatment by crossover rotation of four major classes","volume":"353","author":"Dickerson","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjmed.2024.10.016_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00325481.2016.1147927","article-title":"Hypertension in young adults","volume":"128","author":"De Venecia","year":"2016","journal-title":"Postgrad Med"},{"issue":"7","key":"10.1016\/j.amjmed.2024.10.016_bib0022","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/CIRCRESAHA.121.318061","article-title":"Arterial stiffness and cardiovascular risk in hypertension","volume":"128","author":"Boutouyrie","year":"2021","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.amjmed.2024.10.016_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajh\/hpab137","article-title":"Prescription patterns for the use of antihypertensive drugs for primary prevention among patients with hypertension in the United Kingdom","volume":"35","author":"Jiao","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjmed.2024.10.016_bib0024","first-page":"26652","article-title":"Initial antihypertensive regimens in newly treated patients: real world evidence from the OneFlorida+ Clinical Research Network","volume":"12","author":"Smith","year":"2023","journal-title":"J Am Hear Assoc J Am Hear Assoc"},{"issue":"6","key":"10.1016\/j.amjmed.2024.10.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057510","article-title":"Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study","volume":"12","author":"Rouette","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.amjmed.2024.10.016_bib0026","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41440-019-0238-2","article-title":"Analysis of antihypertensive treatment using real-world Japanese data\u2014the retrospective study of antihypertensives for lowering blood pressure (REAL) study","volume":"42","author":"Ohishi","year":"2019","journal-title":"Hypertens Res"},{"issue":"7","key":"10.1016\/j.amjmed.2024.10.016_bib0027","article-title":"First-line diuretics versus other classes of antihypertensive drugs for hypertension","volume":"2023","author":"Reinhart","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.amjmed.2024.10.016_bib0028","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/ajh\/hpv134","article-title":"Impact of antihypertensive agents on central systolic blood pressure and augmentation index: a meta-analysis","volume":"29","author":"McGaughey","year":"2016","journal-title":"Am J Hypertens"},{"issue":"23","key":"10.1016\/j.amjmed.2024.10.016_bib0029","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"Furberg","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2024.10.016_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Park Relat Disord"},{"issue":"10414","key":"10.1016\/j.amjmed.2024.10.016_bib0031","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(23)01733-6","article-title":"\u03b2 blockers switched to first-line therapy in hypertension","volume":"402","author":"Messerli","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.amjmed.2024.10.016_bib0032","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/HYPERTENSIONAHA.120.16402","article-title":"Comprehensive comparative effectiveness and safety of first-line \u03b2-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study","volume":"77","author":"You","year":"2021","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.amjmed.2024.10.016_bib0033","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"10305","key":"10.1016\/j.amjmed.2024.10.016_bib0034","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(21)01922-X","article-title":"Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial","volume":"398","author":"Chow","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2024.10.016_bib0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2018.10359","article-title":"Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka a randomized clinical trial","volume":"320","author":"Webster","year":"2018","journal-title":"JAMA - J Am Med Assoc"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324006454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324006454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:49:51Z","timestamp":1753361391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934324006454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0002934324006454"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.10.016","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Analysis of First-Line Antihypertensive Treatment Classes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}